Crouser, E. D., Maier, L. A., Baughman, R. P., Abston, E., Bernstein, R. C., Blankstein, R., Bonham, C. A., Chen, E. S., Culver, D. A., Drake, W., Drent, M., Gerke, A. K., Ghobrial, M., Govender, P., Hamzeh, N., James, W. E., Judson, M. A., Kellermeyer, L., Knight, S. ... Wilson, K. C. (2020).
Diagnosis and Detection of Sarcoidosis An Official American Thoracic Society Clinical Practice Guideline.
American Journal of Respiratory and Critical Care Medicine,
201(8), E26-E51.
https://doi.org/10.1164/RCCM.202002-0251ST
Juul, A. D., Falster, C.
, Rasmussen, T. R., Hilberg, O., Jacobsen, N., Arshad, A. & Laursen, C. B. (2022).
Does the Addition of Radial Endobronchial Ultrasound Improve the Diagnostic Yield of Electromagnetic Navigation Bronchoscopy? A Systematic Review.
Respiration,
101(9), 869-877.
https://doi.org/10.1159/000524671
Pedersen, O. S., Rudolf, F., Johansen, I. S., Andersen, Å. B., Lillebæk, T.
, Wejse, C. M. & Dahl, V. N. (2024).
Drug-resistant tuberculosis is a global cause of concern.
Ugeskrift for Laeger,
186(10), Article V11230698.
https://doi.org/10.61409/V11230698
Antoniou, K. M., Vasarmidi, E., Russell, A. M., Andrejak, C., Crestani, B., Delcroix, M., Dinh-Xuan, A. T.
, Poletti, V., Sverzellati, N., Vitacca, M., Witzenrath, M., Tonia, T. & Spanevello, A. (2022).
European Respiratory Society statement on long COVID follow-up.
European Respiratory Journal,
60(2), Article 2102174.
https://doi.org/10.1183/13993003.02174-2021
Pietersen, P. I., Bhatnagar, R., Rahman, N. M., Maskell, N., Wrightson, J. M., Annema, J., Crombag, L., Farr, A., Tabin, N., Slavicky, M.
, Skaarup, S. H., Konge, L. & Laursen, C. B. (2023).
Evidence-based training and certification: the ERS thoracic ultrasound training programme.
Breathe,
19(2), Article 230053.
https://doi.org/10.1183/20734735.0053-2023
Dahl, V. N., Mølhave, M., Fløe, A., van Ingen, J., Schön, T., Lillebaek, T., Andersen, A. B.
& Wejse, C. (2022).
Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review.
International Journal of Infectious Diseases,
125, 120-131.
https://doi.org/10.1016/j.ijid.2022.10.013
Porsbjerg, C. M., Menzies-Gow, A. N., Tran, T. N., Murray, R. B., Unni, B., Audrey Ang, S. L., Alacqua, M., Al-Ahmad, M., Al-Lehebi, R., Altraja, A., Belevskiy, A. S., Björnsdóttir, U. S., Bourdin, A., Busby, J., Canonica, G. W., Christoff, G. C., Cosio, B. G., Costello, R. W., FitzGerald, J. M. ... van Boven, J. F. M. (2022).
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma.
Journal of Allergy and Clinical Immunology: In Practice,
10(5), 1202-1216.e23.
https://doi.org/10.1016/j.jaip.2021.12.027
Desai, S. R., Sivarasan, N., Johannson, K. A., George, P. M., Culver, D. A., Devaraj, A., Lynch, D. A., Milne, D., Renzoni, E., Nunes, H., Sverzellati, N., Spagnolo, P., Baughman, R. P., Yadav, R., Piciucchi, S., Walsh, S. L. F., Kouranos, V., Wells, A. U. & Sarcoid Delphi Group (2024).
High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study.
The Lancet Respiratory Medicine,
12(5), 409-418.
https://doi.org/10.1016/S2213-2600(23)00267-9
Wuyts, W. A., Wijsenbeek, M., Bondue, B., Bouros, D., Bresser, P., Robalo Cordeiro, C.
, Hilberg, O., Magnusson, J., Manali, E. D., Morais, A., Papiris, S., Shaker, S., Veltkamp, M.
& Bendstrup, E. (2020).
Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease.
Respiration,
99(1), 73-82.
https://doi.org/10.1159/000504763
Hassan, M., Touman, A. A., Grabczak, E. M.
, Skaarup, S. H., Faber, K., Blyth, K. G. & Pochepnia, S. (2024).
Imaging of pleural disease.
Breathe,
20(1), Article 230172.
https://doi.org/10.1183/20734735.0172-2023
Senti, G., Freiburghaus, A. U., Larenas-Linnemann, D.
, Hoffmann, H. J., Patterson, A. M., Klimek, L., Di Bona, D., Pfaar, O., Ahlbeck, L., Akdis, M., Weinfeld, D., Contreras-Verduzco, F. A., Pedroza-Melendez, A.
, Skaarup, S. H., Lee, S. M., Cardell, L. O.
, Schmid, J. M., Westin, U., Dollner, R. & Kündig, T. M. (2019).
Intralymphatic Immunotherapy: Update and Unmet Needs.
International Archives of Allergy and Immunology,
178(2), 141-149.
https://doi.org/10.1159/000493647
Cuneo, A., Barosi, G., Danesi, R., Fagiuoli, S., Ghia, P., Marzano, A., Montillo, M.
, Poletti, V., Viale, P. & Zinzani, P. L. (2019).
Management of adverse events associated with idelalisib treatment in chronic lymphocytic leukemia and follicular lymphoma: A multidisciplinary position paper.
Hematological Oncology,
37(1), 3-14.
https://doi.org/10.1002/hon.2540
Jönsson, Å. L. M., Hilberg, O.
, Simonsen, U., Christensen, J. H. & Bendstrup, E. (2023).
New insights in the genetic variant spectrum of SLC34A2 in pulmonary alveolar microlithiasis; a systematic review.
Orphanet Journal of Rare Diseases,
18, Article 130.
https://doi.org/10.1186/s13023-023-02712-7
Bendstrup, E., Wuyts, W., Alfaro, T., Chaudhuri, N., Cornelissen, R., Kreuter, M.
, Melgaard Nielsen, K., Münster, A. M. B., Myllärniemi, M., Ravaglia, C., Vanuytsel, T. & Wijsenbeek, M. (2019).
Nintedanib in idiopathic pulmonary fibrosis: Practical management recommendations for potential adverse events.
Respiration,
97(2), 173-184.
https://doi.org/10.1159/000495046